Getting started with cannabis for seniors — start low, go slow

TL;DR

• Start: 1–2.5 mg THC or CBD-dominant, evening, oral.
• Increase no sooner than after 3-7 days, in small steps of 1–2.5 mg.
• Goal: lowest effective dose, no intoxication.
• Swiss access: medical prescription, potentially FOPH exceptional authorisation (Art. 8 Narcotics Act); OKP coverage only case-by-case.

Why 'start low, go slow' matters especially for seniors

Reduced liver function, lower body water and altered fat distribution markedly slow THC clearance in older people (MacCallum 2018). A dose unproblematic for a 30-year-old can cause pronounced sedation, confusion or falls in a 75-year-old. Hence: lower starting dose, longer observation intervals, oral rather than inhaled intake for better control despite delayed onset.

Concrete titration schedule

Week 1: 1–2.5 mg THC (or a CBD-dominant 20:1 blend) in the evening. Week 2: if well tolerated, increase to 2.5–5 mg. Then increase by 1–2.5 mg every 3–7 days until the desired effect is reached with minimal side effects — typical maintenance doses are 5–15 mg THC/day, markedly below doses common in younger populations.

• Before starting: review the current medication list (see the Polypharmacy spoke).
• Measure blood pressure before/after the first dose, especially standing.
• Keep a diary of dose, timing, effect and side effects.
• No concurrent alcohol consumption during titration.

Access and cost coverage in Switzerland

Since the 2022 legal change (Art. 8 Narcotics Act), many cannabis-based medicines no longer require a special FOPH authorisation but are prescribed via a regular narcotics prescription. For magistral formulations or special indications, an exceptional authorisation may still be needed. Coverage by the mandatory health insurance (OKP) is not automatic and generally requires a reasoned application under Art. 71a/71b KVV with medical documentation of efficacy.

Distinction between medical cannabis and over-the-counter CBD products

In Switzerland, it is of central importance for elderly people to distinguish between prescribed medical cannabis and over-the-counter CBD products. Hemp products with a total THC content of less than one percent are not subject to the Narcotics Act and are freely accessible on the market. However, these products, which are often declared as cosmetics or dietary supplements, do not undergo the strict quality controls of the Swiss authorization authority Swissmedic. For a reliable therapeutic application in old age, standardized active ingredient contents are essential, as this is the only way to ensure precise dosing and avoid undesirable side effects.

Medical cannabis, on the other hand, which can also contain higher levels of THC, has been subject to a strict prescription requirement since the statutory amendment in August 2022. These preparations are dispensed in specialized pharmacies as magistral formulas or authorized medicinal products. Seniors should refrain from self-medicating with over-the-counter oils when it comes to treating chronic ailments. The lack of standardization of these products makes the controlled titration of the dose significantly more difficult and carries the risk of contamination or inaccurate active ingredient specifications, which jeopardizes the success of the therapy.

• Products with less than one percent THC are not considered narcotics in Switzerland and are available without a prescription.
• Medical cannabis preparations are subject to the strict quality and purity standards of Swissmedic.
• Standardized active ingredient concentrations are absolutely essential for safe dosing in old age.
• Over-the-counter CBD oils often exhibit quality fluctuations and are not certified for medical therapies.

Risks of polypharmacy and interactions with existing medication

Many older people in Switzerland take several medications daily due to multiple chronic conditions. With this pronounced polypharmacy, there is an increased risk of interactions, as cannabinoids such as THC and CBD are metabolised in the liver by the same enzymes as many conventional medicines. This can lead to the effects of blood thinners, cardiovascular drugs, or cholesterol-lowering agents being unpredictably enhanced or weakened. Careful coordination of the entire medication plan with the treating physician is therefore mandatory before starting cannabis therapy.

In addition to pharmacokinetic interactions, the additive effects on the central nervous system must also be considered. The combination of medical cannabis with sleeping aids, strong painkillers, or sedatives can lead to pronounced drowsiness, confusion, and an increased risk of falls. Should uncertainties or acute symptoms of overdose occur during the course of therapy, the Swiss emergency number 145 from Tox Info Suisse offers free and expert advice around the clock for those affected and their relatives, to quickly clarify risks in the home environment.

• The metabolism of cannabinoids via liver enzymes can alter the concentration of other vital medications in the blood.
• Particular caution is advised when taking anticoagulants and antihypertensives simultaneously.
• Additive effects with other depressant medications increase the risk of dizziness and falls in daily life.
• The emergency number 145 from Tox Info Suisse is the central point of contact in case of suspected adverse interactions.

Practical handling and avoidance of intake errors

The correct administration of medical cannabis requires precise handling and a lot of patience in daily life. Since oral dosage forms such as drops or capsules are preferentially prescribed for older patients, application errors play a significant role. A common error is taking an additional dose prematurely because the effect is not immediately felt after the first intake. Oral preparations must pass through the gastrointestinal tract and often only develop their effect after several hours, which is why premature redosing leads to an undesirable accumulation of the active ingredients.

In addition, counting drops accurately using a pipette requires good eyesight and fine motor skills, which can pose a barrier in advanced age. In such cases, it is advisable to use dosing aids or to have the administration organised by relatives or the responsible Spitex service. The storage of the medications must always be protected from light, cool, and absolutely childproof to rule out mix-ups in the household. A structured intake diary, in which the dose, time, and well-being are recorded, protects against forgetfulness and double dosing.

• The delayed onset of action with oral intake requires a waiting period of several hours before taking another dose.
• Fine motor limitations when administering drops can be compensated for with the support of caregivers or relatives.
• Medical cannabis must always be stored out of reach of unauthorized persons and protected from light.
• A written dosing log prevents administration errors and facilitates subsequent medical adjustments.

Cantonal differences and daily care routines in Swiss institutions

Although the legal framework for prescribing medical cannabis has been uniformly regulated throughout Switzerland since August 2022, the reality in nursing practice is highly varied. The handling of medical cannabis in retirement and nursing homes, as well as by Spitex organizations, varies significantly depending on the canton and institution. While some progressive homes have already established standardized processes for the storage and administration of narcotics, patients in other facilities still encounter organizational hurdles or reservations on the part of the nursing staff.

For seniors and their relatives, it is therefore advisable to clarify the willingness to support cannabis therapy with the home management or nursing service at an early stage. Since nursing staff bear legal responsibility for administering medication, all medical prescriptions must be documented with absolute precision and without gaps. Cantonal therapeutic products authorities strictly monitor the trade in narcotics, which is why homes must keep detailed logs—this may temporarily increase the administrative burden in daily care, but guarantees the safety of everyone involved.

• The administration of medical cannabis in nursing homes depends heavily on the internal guidelines of the respective institution.
• Seamless medical prescriptions are the legal prerequisite for the administration of medication by nursing staff.
• Cantonal differences in the enforcement of the Narcotics Act can influence the administrative burden in the home.
• Early consultation with the nursing management prevents delays in continuing an existing therapy.

FAQ